Literature DB >> 15712084

Structured treatment interruptions: a risky business.

Julio Montaner, Marianne Harris, Robert Hogg.   

Abstract

Mesh：

Year:  2005        PMID： 15712084     DOI： 10.1086/427707

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques.

Authors:  Koen K A Van Rompay; Raman P Singh; Walid Heneine; Jeffrey A Johnson; David C Montefiori; Norbert Bischofberger; Marta L Marthas
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Piecewise HIV virus dynamic model with CD4(+) T cell count-guided therapy: I.

Authors:  Sanyi Tang; Yanni Xiao; Ning Wang; Hulin Wu
Journal:  J Theor Biol       Date:  2012-05-31       Impact factor: 2.691

3.  Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.

Authors:  Gilles Pialoux; Romina P Quercia; Hanne Gahery; Nathalie Daniel; Laurence Slama; Pierre-Marie Girard; Philippe Bonnard; Willy Rozenbaum; Véronique Schneider; Dominique Salmon; Jean-Gérard Guillet
Journal:  Clin Vaccine Immunol       Date:  2008-01-09

4.  Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence In Vitro.

Authors:  Rima K Acosta; Michelle L D'Antoni; Andrew Mulato; Stephen R Yant; Tomas Cihlar; Kirsten L White
Journal:  Antimicrob Agents Chemother       Date:  2022-04-07       Impact factor: 5.938
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.